Quel est le site Web ?

Altertox Academy

Accueil
België
Bruxelles / Brussel
Altertox Academy

Itinéraire Site Web Contacter l'entreprise

Altertox Academy follows CAAT Academy (2016-2017) with the same team and the same quality. VAT. BE.0 Altertox Academy connects experts from Europe and the U.S.

to provide hands-on-training (HOT) in human-relevant alternative methods and technologies for toxicologists of all levels of experience, from operational to PhD.

21/10/2026

Policy update | How can regulatory sandboxes support the next generation of medicines?

A regulatory sandbox establishes a time-limited framework in which developers can design, validate and test innovative medicines or methodologies in a controlled, real-world environment, under strict regulatory oversight.

What does this mean for EU pharmaceutical legislation?

The new framework allows regulatory sandboxes to be considered when genuine scientific or technical barriers prevent the development of innovative medicines under existing requirements. The aim is to explore targeted regulatory adaptations and generate learnings for future regulatory approaches, without compromising quality, safety or efficacy.

🤝 On 21 September 2026, the European Commission (EC) and the European Medicines Agency (EMA) held a multi-stakeholder workshop to discuss how regulatory sandboxes can be implemented in practice.

Explore the presentations: https://www.ema.europa.eu/en/events/regulatory-sandboxes-joint-european-commission-ec-european-medicines-agency-ema-multi-stakeholder-workshop

20/10/2026

From marine pollution to animal-free chemical safety, our EU Horizon projects are driving progress towards a healthier future. 🌊🔬

Discover this month’s highlights, from the launch of HARMONY and its mission to better understand marine pollutants and their impacts on ocean health under changing climate conditions, to NAMWISE, ONTOX, and PrecisionTox presenting their latest advances at EUROTOX 2026.

➡️ Swipe through the carousel to explore the latest updates and see how our projects and partners are contributing to safer science and healthier oceans.

📬 Stay connected with Altertox and receive fresh insights from our projects and the European research community every month through our newsletter.

15/10/2026

💬 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗨𝗽𝗱𝗮𝘁𝗲 | 𝗪𝗵𝘆 𝗮𝗿𝗲 𝘀𝗼 𝗺𝗮𝗻𝘆 𝗿𝗲𝗮𝗱-𝗮𝗰𝗿𝗼𝘀𝘀 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵𝗲𝘀 𝗿𝗲𝗷𝗲𝗰𝘁𝗲𝗱 𝗯𝘆 𝗘𝗖𝗛𝗔, 𝗮𝗻𝗱 𝘄𝗵𝗮𝘁 𝗰𝗮𝗻 𝗯𝗲 𝗱𝗼𝗻𝗲 𝘁𝗼 𝗶𝗺𝗽𝗿𝗼𝘃𝗲 𝘁𝗵𝗲𝗶𝗿 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗮𝗰𝗰𝗲𝗽𝘁𝗮𝗻𝗰𝗲?

Read-across is an important approach under the EU REACH Regulation to fill data gaps and reduce potentially unnecessary animal testing. Yet its acceptance in regulatory compliance checks remains challenging.

A new study published in 𝘈𝘓𝘛𝘌𝘟 by Roe et al. examines 2,722 European Chemicals Agency (ECHA) compliance check decisions from 2010 to 2025 to identify why read-across approaches fail.

🔬 𝗧𝗵𝗲 𝗸𝗲𝘆 𝗳𝗶𝗻𝗱𝗶𝗻𝗴: demonstrating chemical similarity is not enough. What else do we need?

👉 Swipe through to learn more

Read the full piece: https://www.altex.org/index.php/altex/article/view/3255

13/10/2026

💡 𝗪𝗵𝗮𝘁 𝗶𝗳 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 𝗺𝗼𝗱𝗲𝗹𝘀 𝗰𝗼𝘂𝗹𝗱 𝗼𝗽𝗲𝗻 𝗻𝗲𝘄 𝗽𝗮𝘁𝗵𝘀 𝘁𝗼 𝗯𝗶𝗼𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆?

The U.S. National Institutes of Health (NIH) is joining forces with the U.S. Department of Energy, Biohub and other partners to advance predictive models of human biology.

🔬 𝗧𝗵𝗲 𝗮𝗺𝗯𝗶𝘁𝗶𝗼𝗻: accelerate scientific discovery by helping researchers investigate disease, identify promising drug targets and prioritise potential treatments for further testing.

👉 Swipe through to learn more

🔗 Read the full NIH announcement: https://www.nih.gov/news-events/news-releases/nih-joins-effort-build-si-ready-data-predictive-models-human-biology

12/10/2026

🧬 What’s new in Life Sciences?

From recent scientific publications to the latest developments in New Approach Methodologies ( ), the ALTERTOX Newsletter brings together key updates and insights from the field every month.

📖 Explore this month’s edition on our website.

📩 Want to keep up with the latest research and innovations? Subscribe to the ALTERTOX Newsletter and have the newest updates delivered straight to your inbox.

09/10/2026

🔬 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗖𝗼𝗿𝗻𝗲𝗿 | 𝗧𝗵𝗲 𝗺𝗲𝘁𝗵𝗼𝗱 𝘄𝗮𝘀 𝗳𝗶𝗻𝗲. 𝗧𝗵𝗲 𝘀𝗮𝗺𝗽𝗹𝗲 𝗻𝗲𝘃𝗲𝗿 𝗿𝗲𝗮𝗰𝗵𝗲𝗱 𝘁𝗵𝗲 𝗰𝗲𝗹𝗹.

Some materials need to be prepared before testing to make them usable in a biological assay.

But here is the catch: 𝘁𝗵𝗲 𝗽𝗿𝗲𝗽𝗮𝗿𝗮𝘁𝗶𝗼𝗻 𝗺𝗲𝘁𝗵𝗼𝗱 𝗰𝗮𝗻 𝗰𝗵𝗮𝗻𝗴𝗲 𝘄𝗵𝗶𝗰𝗵 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗺𝗮𝘁𝗲𝗿𝗶𝗮𝗹 𝗮𝗰𝘁𝘂𝗮𝗹𝗹𝘆 𝗿𝗲𝗮𝗰𝗵𝗲𝘀 𝘁𝗵𝗲 𝗰𝗲𝗹𝗹𝘀. 🧪

A new paper in 𝗡𝗔𝗠 𝗝𝗼𝘂𝗿𝗻𝗮𝗹 tested 𝟳 𝗽𝗼𝗼𝗿𝗹𝘆 𝘄𝗮𝘁𝗲𝗿-𝘀𝗼𝗹𝘂𝗯𝗹𝗲 (𝗽𝗿𝗲)𝗽𝗼𝗹𝘆𝗺𝗲𝗿𝘀 𝗮𝗰𝗿𝗼𝘀𝘀 𝟰 𝗵𝘂𝗺𝗮𝗻 𝗵𝗲𝗮𝗹𝘁𝗵 𝗡𝗔𝗠𝘀, showing that 𝘀𝗮𝗺𝗽𝗹𝗲 𝗽𝗿𝗲𝗽𝗮𝗿𝗮𝘁𝗶𝗼𝗻 𝗰𝗮𝗻 𝗯𝗲 𝗱𝗲𝗰𝗶𝘀𝗶𝘃𝗲 𝗳𝗼𝗿 𝘀𝘂𝗰𝗰𝗲𝘀𝘀𝗳𝘂𝗹 𝘁𝗲𝘀𝘁𝗶𝗻𝗴.

➡️ Swipe to see why sample preparation matters.

📖 Read the full paper: https://pubmed.ncbi.nlm.nih.gov/42757074/

07/10/2026

📢 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗨𝗽𝗱𝗮𝘁𝗲 | 𝗚𝗹𝗼𝗯𝗮𝗹 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘀 𝗰𝗮𝗹𝗹 𝘁𝗼 𝗮𝗱𝘃𝗮𝗻𝗰𝗲 𝗮𝗹𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝘃𝗲𝘀 𝘁𝗼 𝗮𝗻𝗶𝗺𝗮𝗹 𝘁𝗲𝘀𝘁𝗶𝗻𝗴

What if reducing animal testing was not just about replacing individual tests — but about changing how medicines are developed and regulated?

The 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗖𝗼𝗮𝗹𝗶𝘁𝗶𝗼𝗻 𝗼𝗳 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗔𝘂𝘁𝗵𝗼𝗿𝗶𝘁𝗶𝗲𝘀 (ICMRA) has adopted a joint statement calling for scientifically valid alternatives to animal testing to be advanced and implemented 𝗮𝗰𝗿𝗼𝘀𝘀 𝘁𝗵𝗲 𝗲𝗻𝘁𝗶𝗿𝗲 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝗹𝗶𝗳𝗲𝗰𝘆𝗰𝗹𝗲.

🔎 𝗦𝘄𝗶𝗽𝗲 𝘁𝗼 𝗱𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝘄𝗵𝗮𝘁 𝘁𝗵𝗶𝘀 𝗰𝗼𝘂𝗹𝗱 𝗺𝗲𝗮𝗻 𝗳𝗼𝗿 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗶𝗼𝗻.

Read the full ICMRA statement: https://www.ema.europa.eu/en/news/global-regulators-call-advancing-alternatives-animal-testing-across-medicine-lifecycle

06/10/2026

Stay up to date on the latest policy and regulatory developments shaping NAMs and non-animal research 👉 https://mailchi.mp/altertox/sep26

29/09/2026

📢 𝗢𝘂𝗿 𝗹𝗮𝘁𝗲𝘀𝘁 𝗔𝗹𝘁𝗲𝗿𝘁𝗼𝘅 𝗻𝗲𝘄𝘀𝗹𝗲𝘁𝘁𝗲𝗿 𝗶𝘀 𝗻𝗼𝘄 𝗹𝗶𝘃𝗲!

The September edition is packed with the current news at the intersection of science, policy & innovation, including:

🔹 The 𝗘𝘅𝗽𝗼𝘀𝗼𝗺𝗲 𝗔𝗹𝗹𝗶𝗮𝗻𝗰𝗲 and its work towards a large-scale European exposome research cohort

🔹 New initiatives from the European Medicines Agency (EMA) to support the uptake of NAMs in regulatory science, alongside new opportunities from EURL ECVAM and the NIH to advance cutting-edge and human-based research

🔹 𝗥𝗲𝗰𝗲𝗻𝘁 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗽𝘂𝗯𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝗲𝘅𝗽𝗹𝗼𝗿𝗶𝗻𝗴 𝗵𝗼𝘄 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵𝗲𝘀 𝗮𝗿𝗲 𝘀𝗵𝗮𝗽𝗶𝗻𝗴 𝗿𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝘀𝗰𝗶𝗲𝗻𝗰𝗲, including advances in , read-across and alternative testing methods, as well as the growing role of AI

🔹 Updates from our EU-funded projects 𝗡𝗔𝗠𝗪𝗜𝗦𝗘, 𝗢𝗡𝗧𝗢𝗫 𝗮𝗻𝗱 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝗧𝗼𝘅, including our participation at 𝗘𝗨𝗥𝗢𝗧𝗢𝗫 𝟮𝟬𝟮𝟲. Plus, a start to our 𝗻𝗲𝘄 𝗽𝗿𝗼𝗷𝗲𝗰𝘁 𝗛𝗔𝗥𝗠𝗢𝗡𝗬, focusing on marine pollution 🌊

🔹 Upcoming events, including , taking place on 8–9 October in Archamps, France

📖 𝗥𝗲𝗮𝗱 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗻𝗲𝘄𝘀𝗹𝗲𝘁𝘁𝗲𝗿:
https://mailchi.mp/altertox/sep26

25/09/2026

📢 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 & 𝗣𝗼𝗹𝗶𝗰𝘆 | 𝗧𝗵𝗲 𝗖𝗡𝗦 𝗶𝘀 𝘄𝗵𝗲𝗿𝗲 𝗡𝗔𝗠𝘀 𝗮𝗻𝗱 𝗔𝗜 𝗺𝗲𝗲𝘁 𝘁𝗵𝗲𝗶𝗿 𝗵𝗮𝗿𝗱𝗲𝘀𝘁 𝘁𝗲𝘀𝘁

How can we improve the prediction of CNS toxicity while reducing reliance on animal testing?

A recent paper explores how 𝗡𝗲𝘄 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵 𝗠𝗲𝘁𝗵𝗼𝗱𝗼𝗹𝗼𝗴𝗶𝗲𝘀 ( #𝗡𝗔𝗠𝘀) 𝗰𝗼𝗺𝗯𝗶𝗻𝗲𝗱 𝘄𝗶𝘁𝗵 𝗔𝗜 could address this challenge, and it raises an important question: What would NAM + AI need to demonstrate before it can support regulatory acceptance?

➡️ Swipe to learn more
👉 Read the full piece: https://pubmed.ncbi.nlm.nih.gov/42573518/

Adresse

Brussels
1050

Site Web

http://academy.altertox.be/

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Altertox Academy publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.